Severe Combined Immunodeficiency (SCID) Questions & Answers

1. Justiz Vaillant AA, Mohseni M. Severe Combined Immunodeficiency. 2020 Jan. [QxMD MEDLINE Link]. [Full Text].

2. Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, et. al. Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017 Jan;139(1):232-245. [QxMD MEDLINE Link].

3. Cavazzana-Calvo M, Fischer A. Gene therapy for severe combined immunodeficiency: are we there yet?. J Clin Invest. 2007 Jun. 117(6):1456-65. [QxMD MEDLINE Link]. [Full Text].

4. Khiong K, Murakami M, Kitabayashi C, et al. Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J Clin Invest. 2007 May. 117(5):1270-81. [QxMD MEDLINE Link]. [Full Text].

5. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000 Apr 28. 288(5466):669-72. [QxMD MEDLINE Link].

6. Kwan A, Abraham RS, Currier R, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014 Aug 20. 312 (7):729-38. [QxMD MEDLINE Link]. [Full Text].

7. Sinha S, Schwartz RA. Severe combined immunodeficiency. Medscape Reference. Updated August 21, 2006. [Full Text].

8. Bonilla FA, Geha RS. 2. Update on primary immunodeficiency diseases. J Allergy Clin Immunol. 2006 Feb. 117(2 suppl mini-primer):S435-41. [QxMD MEDLINE Link].

9. Cachafeiro T, Escobar G, Bakos L, Bakos R. Chronic cutaneous cytomegalovirus infection in a patient with severe combined immunodeficiency syndrome. Br J Dermatol. 2013 Sep 6. [QxMD MEDLINE Link].

10. Kwan A, Puck JM. History and current status of newborn screening for severe combined immunodeficiency. Semin Perinatol. 2015 Apr. 39 (3):194-205. [QxMD MEDLINE Link]. [Full Text].

11. Bacalhau S, Freitas C, Valente R, Barata D, Neves C, Schäfer K, et al. Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency. Case Report Med. 2011. 2011:527569. [QxMD MEDLINE Link]. [Full Text].

12. Verbsky JW, Baker MW, Grossman WJ, Hintermeyer M, Dasu T, Bonacci B, et al. Newborn Screening for Severe Combined Immunodeficiency; The Wisconsin Experience (2008-2011). J Clin Immunol. 2011 Nov 10. [QxMD MEDLINE Link].

13. Somech R, Lev A, Simon AJ, Korn D, Garty BZ, Amariglio N, et al. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study. Isr Med Assoc J. 2013 Aug. 15(8):404-9. [QxMD MEDLINE Link].

14. Kelly BT, Tam JS, Verbsky JW, Routes JM. Screening for severe combined immunodeficiency in neonates. Clin Epidemiol. 2013 Sep 16. 5:363-369. [QxMD MEDLINE Link]. [Full Text].

15. Rozmus J, Junker A, Thibodeau ML, Grenier D, Turvey SE, Yacoub W, et al. Severe Combined Immunodeficiency (SCID) in Canadian Children: A National Surveillance Study. J Clin Immunol. 2013 Oct 12. [QxMD MEDLINE Link].

16. Zhang C, Zhang ZY, Wu JF, Tang XM, Yang XQ, Jiang LP, et al. Clinical characteristics and mutation analysis of X-linked severe combined immunodeficiency in China. World J Pediatr. 2011 Nov 21. [QxMD MEDLINE Link].

17. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997 Jul. 131(1 pt 1):47-54. [QxMD MEDLINE Link].

18. Ridanpaa M, van Eenennaam H, Pelin K, et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell. 2001 Jan 26. 104(2):195-203. [QxMD MEDLINE Link]. [Full Text].

19. IDF SCID Newborn Screening Campaign. Immune Deficiency Foundation. Available at https://primaryimmune.org/idf-advocacy-center/idf-scid-newborn-screening-campaign. Accessed: May 28, 2020.

20. van der Spek J, Groenwold RH, van der Burg M, van Montfrans JM. TREC Based Newborn Screening for Severe Combined Immunodeficiency Disease: A Systematic Review. J Clin Immunol. 2015 May. 35 (4):416-30. [QxMD MEDLINE Link]. [Full Text].

21. Verhagen MV, Trevisan V, Adu J, Owens CM, Booth C, Calder A. Chest Radiographs for Distinguishing ADA-SCID from Other Forms of SCID. J Clin Immunol. 2020 Feb. 40 (2):259-266. [QxMD MEDLINE Link].

22. Chin T, Alonazi N. B-cell and T-cell combined disorders. Medscape Reference. Updated April 5, 2007. [Full Text].

23. Bertrand Y, Landais P, Friedrich W, et al. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European Group for Bone Marrow Transplantation and the European Society for Immunodeficiency. J Pediatr. 1999 Jun. 134(6):740-8. [QxMD MEDLINE Link].

24. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999 Feb 18. 340(7):508-16. [QxMD MEDLINE Link]. [Full Text].

25. Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant. 2000 Jun. 25(12):1303-5. [QxMD MEDLINE Link].

26. Castiello MC, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015 Sep. 136 (3):692-702.e2. [QxMD MEDLINE Link]. [Full Text].

27. Fischer A, Hacein-Bey-Abina S. Gene therapy for severe combined immunodeficiencies and beyond. J Exp Med. 2020 Jan 6. 217 (2):[QxMD MEDLINE Link]. [Full Text].

28. Kohn DB, Hershfield MS, Puck JM, Aiuti A, Blincoe A, Gaspar HB, et al. Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency. J Allergy Clin Immunol. 2018 Sep 5. [QxMD MEDLINE Link].

29. Atluri S, Neville K, Davis M, et al. Epstein-Barr-associated leiomyomatosis and T-cell chimerism after haploidentical bone marrow transplantation for severe combined immunodeficiency disease. J Pediatr Hematol Oncol. 2007 Mar. 29(3):166-72. [QxMD MEDLINE Link].

30. Husain M, Grunebaum E, Naqvi A, et al. Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase. J Pediatr. 2007 Jul. 151(1):93-5. [QxMD MEDLINE Link].

31. Hadzic N, Pagliuca A, Rela M, et al. Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. N Engl J Med. 2000 Feb 3. 342(5):320-4. [QxMD MEDLINE Link]. [Full Text].

32. Zhu Q, Watanabe C, Liu T, et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 1997 Oct 1. 90(7):2680-9. [QxMD MEDLINE Link]. [Full Text].

33. Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. . 2015 Nov;35(8):696-726. [QxMD MEDLINE Link]. [Full Text].

34. Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol. 2014 Apr;133(4):1092-8. [QxMD MEDLINE Link]. [Full Text].

35. Wiekmeijer AS, Pike-Overzet K, IJspeert H, Brugman MH, Wolvers-Tettero IL, Lankester AC, et al. Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells. J Allergy Clin Immunol. 2016 Feb;137(2):517-526. [QxMD MEDLINE Link].

36. Tagliaferri L, Kunz JB, Happich M, Esposito S, Bruckner T, Hübschmann D, et al. Newborn screening for severe combined immunodeficiency using a novel and simplified method to measure T-cell excision circles (TREC). Clin Immunol. 2017 Feb;175:51-55. [QxMD MEDLINE Link].

37. Rezaei N, Aghamohammadi A, Notarangelo L D. Primary Immunodeficiency Diseases. Springer Berlin Heidelberg; December 2016. 83-182. [Full Text].

Francisco J Hernandez-Ilizaliturri, MD Professor of Medicine, Department of Medical Oncology, Associate Professor of Immunology, Department of Immunology, Chief, Lymphoma and Myeloma Section, Director, The Lymphoma Translational Research Program, Roswell Park Cancer Institute, University of Buffalo State University of New York School of Medicine and Biomedical Sciences

Francisco J Hernandez-Ilizaliturri, MD is a member of the following medical societies: American Association for Cancer Research, American Society of Hematology

Disclosure: Nothing to disclose.

Mohammad Muhsin Chisti, MD, FACP Associate Professor of Medicine (Hematology and Oncology), Oakland University William Beaumont School of Medicine; Medical Director of Research, Karmanos Cancer Institute

Mohammad Muhsin Chisti, MD, FACP is a member of the following medical societies: American College of Physicians, American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Medical Society of the State of New York

Disclosure: Nothing to disclose.

Issam Makhoul, MD Laura F Hutchins, MD, Distinguished Chair of Hematology and Oncology, Professor of Medicine, Co-Chair, Breast Cancer Disease Oriented Committee, Director of Hematology/Oncology Division, Department of Internal Medicine, University of Arkansas for Medical Sciences College of Medicine

Issam Makhoul, MD is a member of the following medical societies: American Society of Clinical Oncology, American Society of Hematology

Disclosure: Nothing to disclose.

David Claxton, MD Professor of Medicine, Department of Internal Medicine, Section of Hematology-Oncology, Hershey Medical Center, Pennsylvania State University College of Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Marcel E Conrad, MD Distinguished Professor of Medicine (Retired), University of South Alabama College of Medicine

Marcel E Conrad, MD is a member of the following medical societies: Alpha Omega Alpha, American Association for the Advancement of Science, American Association of Blood Banks, American Chemical Society, American College of Physicians, American Physiological Society, American Society for Clinical Investigation, American Society of Hematology, Association of American Physicians, Association of Military Surgeons of the US, International Society of Hematology, Society for Experimental Biology and Medicine, SWOG

Disclosure: Partner received none from No financial interests for none.

Emmanuel C Besa, MD Professor Emeritus, Department of Medicine, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University

Emmanuel C Besa, MD is a member of the following medical societies: American Association for Cancer Education, American Society of Clinical Oncology, American College of Clinical Pharmacology, American Federation for Medical Research, American Society of Hematology, New York Academy of Sciences

Disclosure: Nothing to disclose.

James O Ballard, MD Kienle Chair for Humane Medicine, Professor, Departments of Humanities, Medicine, and Pathology, Division of Hematology/Oncology, Milton S Hershey Medical Center, Pennsylvania State University College of Medicine

James O Ballard, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, and American Society of Hematology

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article